LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Search

Microbot Medical Inc

Затворен

1.77 -2.21

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.77

Максимум

1.83

Ключови измерители

By Trading Economics

Приходи

-207K

-3.7M

Продажби

105K

105K

EPS

-0.05

Марж на печалбата

-3,496.19

Служители

43

EBITDA

-180K

-4.3M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+293.96% upside

Дивиденти

By Dow Jones

Следващи печалби

10.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-25M

122M

Предишно отваряне

3.98

Предишно затваряне

1.77

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.06.2026 г., 23:36 ч. UTC

Печалби

Correction to Oracle Reports Higher 4Q Profit Article

10.06.2026 г., 23:19 ч. UTC

Горещи акции

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10.06.2026 г., 23:09 ч. UTC

Значими двигатели на пазара

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10.06.2026 г., 23:04 ч. UTC

Печалби

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10.06.2026 г., 20:44 ч. UTC

Значими двигатели на пазара

Caterpillar Raises Quarterly Dividend 8%

10.06.2026 г., 23:49 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Northern Star Should Take No Options Off The Table

10.06.2026 г., 23:48 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10.06.2026 г., 23:48 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10.06.2026 г., 23:47 ч. UTC

Пазарно говорене

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10.06.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10.06.2026 г., 23:46 ч. UTC

Придобивния, сливания и поглъщания

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

10.06.2026 г., 23:38 ч. UTC

Пазарно говорене

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10.06.2026 г., 23:32 ч. UTC

Пазарно говорене

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10.06.2026 г., 23:20 ч. UTC

Пазарно говорене

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10.06.2026 г., 22:05 ч. UTC

Пазарно говорене

Correction to Bank of Canada Stays on Hold Market Talk

10.06.2026 г., 21:57 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:52 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:35 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 21:22 ч. UTC

Печалби

Oracle Stock Slides on Increased Capital Spending -- WSJ

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

10.06.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

10.06.2026 г., 20:39 ч. UTC

Пазарно говорене
Печалби

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10.06.2026 г., 20:34 ч. UTC

Печалби

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10.06.2026 г., 20:33 ч. UTC

Печалби

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10.06.2026 г., 20:33 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

10.06.2026 г., 20:33 ч. UTC

Пазарно говорене
Печалби

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

293.96% нагоре

12-месечна прогноза

Среден 7.17 USD  293.96%

Висок 12 USD

Нисък 4 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat